|
| Read more ›› |
|
By: GlobenewsWire - 12 Jun 2020
|
|
Related companies:
Burning Rock Biotech |
|
|
SUZHOU, China, June 11, 2020 /PRNewswire/ -- GeneQuantum Healthcare (GQ) has recently received the US IND approval for its in-house developed next generation antibody drug conjugate (ADC) asset, GQ1001. This is the world's first site-specific ADC produced using the intelligent ligase-dependent... Read more ›› |
|
By: PR Newswire Association LLC. - 11 Jun 2020
|
|
Related companies:
GeneQuantum Healthcare (Suzhou) Co., Ltd. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 11 Jun 2020
|
|
|
SHANGHAI, June 10, 2020 /PRNewswire/ -- Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing. Read more ›› |
|
By: PR Newswire Association LLC. - 10 Jun 2020
|
|
Related companies:
Shanghai ChemPartner Co., Ltd. |
|
|
SUZHOU, China, June 9, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a partnership agreement with Institut Pasteur of Shanghai, Chinese Academy... Read more ›› |
|
By: PR Newswire Association LLC. - 10 Jun 2020
|
|
Related companies:
Alphamab Oncology |
|
|
| Read more ›› |
|
By: GlobenewsWire - 09 Jun 2020
|
|
|
SUZHOU, China, June 8, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology, and Sanofi (EURONEXT: SAN and NASDAQ: SNY), a global biopharmaceutical leader, announced today that Jiangsu Alphamab... Read more ›› |
|
By: PR Newswire Association LLC. - 09 Jun 2020
|
|
Related companies:
Alphamab Oncology |
|
|
SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ›› |
|
By: PR Newswire Association LLC. - 09 Jun 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 08 Jun 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 05 Jun 2020
|
|
Related companies:
BeiGene, Ltd. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 04 Jun 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 03 Jun 2020
|
|
Related companies:
BeiGene, Ltd. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 03 Jun 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 03 Jun 2020
|
|
|
SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announces... Read more ›› |
|
By: PR Newswire Association LLC. - 03 Jun 2020
|
|
Related companies:
Innovent Biologics Co., Ltd. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 02 Jun 2020
|
|
Related companies:
Anpac Technology USA (Anpac Bio) |
AnPac Bio-Medical Science Co., Ltd. |
|
|
| Read more ›› |
|
By: GlobenewsWire - 02 Jun 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 02 Jun 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 02 Jun 2020
|
|
|
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announces... Read more ›› |
|
By: PR Newswire Association LLC. - 02 Jun 2020
|
|
Related companies:
Innovent Biologics Co., Ltd. |
|
|
|
|
|
Biotechgate Global Database ›
